On the public citation graph
Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results
0 signed · 87 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/0471142735.im1521s81openalex-snapshot
Creation of “Humanized” Mice to Study Human Immunity
inferredcites →https://doi.org/10.1002/ijc.28289openalex-snapshot
Targeting breast cancer-initiating/stem cells with melanoma differentiation-associated gene-7/interleukin-24
inferredcites →https://doi.org/10.1007/s00262-003-0485-5openalex-snapshot
Dendritic cells are dysfunctional in patients with operable breast cancer
inferredcites →https://doi.org/10.1007/s00262-011-1192-2openalex-snapshot
Autologous dendritic cell vaccine for estrogen receptor (ER)/progestin receptor (PR) double-negative breast cancer
inferredcites →https://doi.org/10.1007/s00262-014-1642-8openalex-snapshot
Long-term clinical outcome of melanoma patients treated with messenger RNA-electroporated dendritic cell therapy following complete resection of metastases
inferredcites →https://doi.org/10.1007/s10549-015-3376-5openalex-snapshot
Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin
inferredcites →https://doi.org/10.1007/s11626-010-9356-5openalex-snapshot
Differentiating of banked human umbilical cord blood-derived mesenchymal stem cells into insulin-secreting cells
inferredcites →https://doi.org/10.1007/s12032-009-9277-xopenalex-snapshot
Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo
inferredcites →https://doi.org/10.1007/s12094-013-1001-9openalex-snapshot
Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument of such contentious therapeutic preferences
inferredcites →https://doi.org/10.1007/s12282-015-0623-xopenalex-snapshot
Pertuzumab, trastuzumab and docetaxel reduced the recurrence of brain metastasis from breast cancer: a case report
inferredcites →https://doi.org/10.1007/s40273-015-0296-5openalex-snapshot
Sipuleucel-T for the Treatment of Metastatic Hormone-Relapsed Prostate Cancer: A NICE Single Technology Appraisal; An Evidence Review Group Perspective
inferredcites →https://doi.org/10.1016/j.clgc.2015.04.006openalex-snapshot
Remarkable Pathologic Change in Advanced Prostate Cancer Patient Using Dendritic Cell–Cytokine-Induced Killer Combined Therapy: A Case Report
inferredcites →https://doi.org/10.1016/j.clim.2009.12.008openalex-snapshot
Parameters for establishing humanized mouse models to study human immunity: Analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rγnull mutation
inferredcites →https://doi.org/10.1016/j.critrevonc.2007.10.002openalex-snapshot
The use of dendritic cells in cancer immunotherapy
inferredcites →https://doi.org/10.1016/j.jss.2011.03.067openalex-snapshot
Combinatorial Therapy for Liver Metastatic Colon Cancer: Dendritic Cell Vaccine and Low-Dose Agonistic Anti-4-1BB Antibody Co-Stimulatory Signal
inferredcites →https://doi.org/10.1016/j.wneu.2011.08.020openalex-snapshot
Adjuvant Immunotherapy with Whole-Cell Lysate Dendritic Cells Vaccine for Glioblastoma Multiforme: A Phase II Clinical Trial
inferredcites →https://doi.org/10.1016/s0092-8674(01)00448-2openalex-snapshot
Dendritic Cells as Vectors for Therapy
inferredcites →https://doi.org/10.1016/s1043-321x(05)80053-0openalex-snapshot
1–33 Fusion Cell Vaccination of Patients With Metastatic Breast and Renal Cancer Induces Immunological and Clinical Responses
inferredcites →https://doi.org/10.1016/s1470-2045(13)70585-0openalex-snapshot
Clinical use of dendritic cells for cancer therapy
inferredcites →https://doi.org/10.1038/mt.2009.58openalex-snapshot
Oncolytic Reovirus Effectively Targets Breast Cancer Stem Cells
inferredcites →https://doi.org/10.1073/pnas.0530291100openalex-snapshot
Prospective identification of tumorigenic breast cancer cells
inferredcites →https://doi.org/10.1093/annonc/mdr372openalex-snapshot
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
inferredcites →https://doi.org/10.1093/annonc/mds232openalex-snapshot
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
inferredcites →https://doi.org/10.1111/bjh.13302openalex-snapshot
Clinical outcomes of a novel therapeutic vaccine with Tax peptide‐pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study
inferredcites →https://doi.org/10.1111/cas.12621openalex-snapshot
Phase I pilot study of Wilms tumor gene 1 peptide‐pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-04-0347openalex-snapshot
Fusion Cell Vaccination of Patients with Metastatic Breast and Renal Cancer Induces Immunological and Clinical Responses
inferredcites →https://doi.org/10.1158/1078-0432.ccr-14-0314openalex-snapshot
Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
inferredcites →https://doi.org/10.1172/jci200421926openalex-snapshot
Progress on new vaccine strategies for the immunotherapy and prevention of cancer
inferredcites →https://doi.org/10.1172/jci21926openalex-snapshot
Progress on new vaccine strategies for the immunotherapy and prevention of cancer
inferredcites →https://doi.org/10.1177/1758834012466280openalex-snapshot
Targeted therapy and immunotherapy in advanced melanoma: an evolving paradigm
inferredcites →https://doi.org/10.1182/blood-2011-05-353243openalex-snapshot
Engraftment of human HSCs in nonirradiated newborn NOD-scid IL2rγnull mice is enhanced by transgenic expression of membrane-bound human SCF
inferredcites →https://doi.org/10.1182/blood.v110.11.1194.1194openalex-snapshot
Low Dose Busulfan Produces Efficient Human Cell Engraftment in Immunodeficient Mice.
inferredcites →https://doi.org/10.1182/blood.v96.9.3102openalex-snapshot
Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells
inferredcites →https://doi.org/10.1186/1479-5876-9-178openalex-snapshot
Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial
inferredcites →https://doi.org/10.1186/1479-5876-9-209openalex-snapshot
Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy
inferredcites →https://doi.org/10.1371/journal.pone.0038491openalex-snapshot
An Improved Protocol for Efficient Engraftment in NOD/LTSZ-SCIDIL-2RγNULL Mice Allows HIV Replication and Development of Anti-HIV Immune Responses
inferredcites →https://doi.org/10.1634/stemcells.2008-0583openalex-snapshot
Busulfan Produces Efficient Human Cell Engraftment in NOD/LtSz-Scid IL2Rγ Null Mice
inferredcites →https://doi.org/10.18632/oncotarget.4337openalex-snapshot
Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cancer patients: a phase 2, open-label, multicenter, randomized trial
inferredcites →https://doi.org/10.2147/ott.s30609openalex-snapshot
Suppression of human breast tumors in NOD/SCID mice by CD44 shRNA gene therapy combined with doxorubicin treatment
inferredcites →https://doi.org/10.2147/ott.s67057openalex-snapshot
A simple in vitro method for evaluating dendritic cell-based vaccinations
inferredcites →https://doi.org/10.2174/0929867322666150416095744openalex-snapshot
Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell Expansion
inferredcites →https://doi.org/10.2217/imt.10.56openalex-snapshot
Enhancement of Dendritic Cells as Vaccines for Cancer
inferredcites →https://doi.org/10.3109/07357907.2014.958234openalex-snapshot
Dendritic Cell-Based Vaccine for the Treatment of Malignant Glioma: A Systematic Review
inferredcites →https://doi.org/10.31768/2312-8852.2015.37(2):146-150openalex-snapshot
LAPATINIB-BASED THERAPY FOR WOMEN WITH ADVANCED/ METASTATIC HER2 POSITIVE BREAST CANCER
inferredcites →https://doi.org/10.36721/pjps/28/3(sup)/2015/209/1055-1058openalex-snapshot
Clinical effects of immunotherapy of DC-CIK combined with chemotherapy in treating patients with metastatic breast cancer
inferredcites →https://doi.org/10.4068/cmj.2015.51.1.1openalex-snapshot
Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic
inferredcites →https://doi.org/10.4103/1477-3163.91119openalex-snapshot
Emerging candidates in breast cancer stem cell maintenance, therapy resistance and relapse
inferredcites →https://doi.org/10.4161/21645515.2014.982993openalex-snapshot
Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies
inferredcites →https://doi.org/10.7150/jca.5046openalex-snapshot
Dendritic Cells in the Cancer Microenvironment
inferredcites →https://doi.org/10.7314/apjcp.2015.16.10.4237openalex-snapshot
Breast Cancer Statistics and Prediction Methodology: A Systematic Review and Analysis
inferredcites →https://doi.org/10.7603/s40730-015-0014-0openalex-snapshot
In vitro spontaneous differentiation of human breast cancer stem cells and methods to control this process
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/ijc.32008openalex-snapshot
An effective dendritic cell‐based vaccine containing glioma stem‐like cell lysate and CpG adjuvant for an orthotopic mouse model of glioma
inferred← citeshttps://doi.org/10.1007/s00262-021-03129-6openalex-snapshot
Efficacy of an ALDH peptide-based dendritic cell vaccine targeting cancer stem cells
inferred← citeshttps://doi.org/10.1007/s00432-022-04303-8openalex-snapshot
Preventive cancer stem cell-based vaccination modulates tumor development in syngeneic colon adenocarcinoma murine model
inferred← citeshttps://doi.org/10.1007/s12032-024-02347-zopenalex-snapshot
Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
inferred← citeshttps://doi.org/10.1007/s12672-025-03493-0openalex-snapshot
Recent advances in immunotherapy for breast cancer
inferred← citeshttps://doi.org/10.1016/j.addr.2021.03.001openalex-snapshot
Preclinical models and technologies to advance nanovaccine development
inferred← citeshttps://doi.org/10.1016/j.biopha.2018.11.101openalex-snapshot
4-Acetylantroquinonol B from antrodia cinnamomea enhances immune function of dendritic cells against liver cancer stem cells
inferred← citeshttps://doi.org/10.1016/j.intimp.2022.108684openalex-snapshot
'Double Hit' Strategy: Removal of Sialic Acid from the Dendritic Cell Surface and Loading with CD44+/CD24-/Low Cell Lysate Inhibits Tumor Growth and Metastasis by Targeting Breast Cancer Stem Cells
inferred← citeshttps://doi.org/10.1016/j.intimp.2023.110696openalex-snapshot
Breast cancer vaccination: Latest advances with an analytical focus on clinical trials
inferred← citeshttps://doi.org/10.1016/j.lfs.2019.01.016openalex-snapshot
Induction of T cell-mediated immune response by dendritic cells pulsed with mRNA of sphere-forming cells isolated from patients with gastric cancer
inferred← citeshttps://doi.org/10.1016/j.omto.2022.08.003openalex-snapshot
PI3K-activated MSC proteomes inhibit mammary tumors via Hsp90ab1 and Myh9
inferred← citeshttps://doi.org/10.1016/j.soc.2019.02.010openalex-snapshot
Immunologic Targeting of Cancer Stem Cells
inferred← citeshttps://doi.org/10.1016/j.treopn.2026.04.001openalex-snapshot
Immunotherapy in pancreatic cancer: overcoming the challenges of tumor heterogeneity
inferred← citeshttps://doi.org/10.1016/j.trsl.2023.10.003openalex-snapshot
Rough neighborhood: Intricacies of cancer stem cells and infiltrating immune cell interaction in tumor microenvironment and potential in therapeutic targeting.
inferred← citeshttps://doi.org/10.1038/s41413-021-00152-2openalex-snapshot
Overexpression of Lrp5 enhanced the anti-breast cancer effects of osteocytes in bone
inferred← citeshttps://doi.org/10.1038/s41598-018-30525-3openalex-snapshot
Cancer stem cells as targets for DC-based immunotherapy of colorectal cancer
inferred← citeshttps://doi.org/10.1093/stmcls/sxac089openalex-snapshot
Efficacy of Whole Cancer Stem Cell-Based Vaccines: A Systematic Review of Preclinical and Clinical Studies
inferred← citeshttps://doi.org/10.1098/rsif.2017.0105openalex-snapshot
Uncovering the underlying mechanism of cancer tumorigenesis and development under an immune microenvironment from global quantification of the landscape
inferred← citeshttps://doi.org/10.1111/1759-7714.13440openalex-snapshot
Expression levels of a gene signature in hiPSC associated with lung adenocarcinoma stem cells and its capability in eliciting specific antitumor immune‐response in a humanized mice model
inferred← citeshttps://doi.org/10.1111/jcmm.16401openalex-snapshot
Dendritic cells loaded with exosomes derived from cancer stem cell‐enriched spheroids as a potential immunotherapeutic option
inferred← citeshttps://doi.org/10.1128/jvi.01967-19openalex-snapshot
Mucin-Like Domain of Ebola Virus Glycoprotein Enhances Selective Oncolytic Actions against Brain Tumors
inferred← citeshttps://doi.org/10.1177/1534735419848047openalex-snapshot
Breast Tumor Cells Highly Resistant to Drugs Are Controlled Only by the Immune Response Induced in an Immunocompetent Mouse Model
inferred← citeshttps://doi.org/10.21294/1814-4861-2023-22-1-82-94openalex-snapshot
Development of in vitro laboratory models of the tumor immune microenvironment to evaluate quality parameters and specific efficacy of the dendritic cell vaccine
inferred← citeshttps://doi.org/10.2174/1568009620666200504111914openalex-snapshot
Immunotherapy: A Potential Approach to Targeting Cancer Stem Cells
inferred← citeshttps://doi.org/10.2217/imt-2018-0103openalex-snapshot
Efficacy of Dendritic Cell-Based Immunotherapy Produced from Cord Blood in vitro and in a Humanized NSG Mouse Cancer Model
inferred← citeshttps://doi.org/10.30895/2221-996x-2023-23-2-148-161openalex-snapshot
Current approaches to quality assessment, non-clinical and clinical studies of dendritic cell vaccines in oncology
inferred← citeshttps://doi.org/10.3389/fimmu.2019.00203openalex-snapshot
Humanized Mouse Models of Rheumatoid Arthritis for Studies on Immunopathogenesis and Preclinical Testing of Cell-Based Therapies
inferred← citeshttps://doi.org/10.3389/fimmu.2024.1477980openalex-snapshot
Integrating immunotherapy with conventional treatment regime for breast cancer patients- an amalgamation of armamentarium
inferred← citeshttps://doi.org/10.3389/fonc.2022.877384openalex-snapshot
Are Cancer Stem Cells a Suitable Target for Breast Cancer Immunotherapy?
inferred← citeshttps://doi.org/10.3390/biomedicines10010035openalex-snapshot
VraSR Regulatory System Contributes to the Virulence of Community-Associated Methicillin-Resistant Staphylococcus aureus (CA-MRSA) in a 3D-Skin Model and Skin Infection of Humanized Mouse Model
inferred← citeshttps://doi.org/10.3390/cancers13225593openalex-snapshot
Conversion of Osteoclasts into Bone-Protective, Tumor-Suppressing Cells
inferred← citeshttps://doi.org/10.3390/curroncol31060232openalex-snapshot
Immunotherapeutic Strategies Targeting Breast Cancer Stem Cells
inferred← citeshttps://doi.org/10.3892/ol.2020.11338openalex-snapshot
Breast cancer stem cell RNA‑pulsed dendritic cells enhance tumor cell killing by effector T�cells�
inferred← citeshttps://doi.org/10.7150/thno.70549openalex-snapshot
Counterintuitive production of tumor-suppressive secretomes from Oct4- and c-Myc-overexpressing tumor cells and MSCs
inferred← citeshttps://doi.org/10.7150/thno.80294openalex-snapshot
Proteomes from AMPK-inhibited peripheral blood mononuclear cells suppress the progression of breast cancer and bone metastasis
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.